295 related articles for article (PubMed ID: 17156977)
1. A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia.
Bendikov I; Nadri C; Amar S; Panizzutti R; De Miranda J; Wolosker H; Agam G
Schizophr Res; 2007 Feb; 90(1-3):41-51. PubMed ID: 17156977
[TBL] [Abstract][Full Text] [Related]
2. d-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia.
Verrall L; Walker M; Rawlings N; Benzel I; Kew JN; Harrison PJ; Burnet PW
Eur J Neurosci; 2007 Sep; 26(6):1657-69. PubMed ID: 17880399
[TBL] [Abstract][Full Text] [Related]
3. Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia.
Madeira C; Freitas ME; Vargas-Lopes C; Wolosker H; Panizzutti R
Schizophr Res; 2008 Apr; 101(1-3):76-83. PubMed ID: 18378121
[TBL] [Abstract][Full Text] [Related]
4. Levels of D-serine in the brain and peripheral organs of serine racemase (Srr) knock-out mice.
Horio M; Kohno M; Fujita Y; Ishima T; Inoue R; Mori H; Hashimoto K
Neurochem Int; 2011 Nov; 59(6):853-9. PubMed ID: 21906644
[TBL] [Abstract][Full Text] [Related]
5. Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels.
Yamada K; Ohnishi T; Hashimoto K; Ohba H; Iwayama-Shigeno Y; Toyoshima M; Okuno A; Takao H; Toyota T; Minabe Y; Nakamura K; Shimizu E; Itokawa M; Mori N; Iyo M; Yoshikawa T
Biol Psychiatry; 2005 Jun; 57(12):1493-503. PubMed ID: 15953485
[TBL] [Abstract][Full Text] [Related]
6. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.
Hashimoto K; Fukushima T; Shimizu E; Komatsu N; Watanabe H; Shinoda N; Nakazato M; Kumakiri C; Okada S; Hasegawa H; Imai K; Iyo M
Arch Gen Psychiatry; 2003 Jun; 60(6):572-6. PubMed ID: 12796220
[TBL] [Abstract][Full Text] [Related]
7. Effects of MK-801 on the expression of serine racemase and d-amino acid oxidase mRNAs and on the D-serine levels in rat brain.
Hashimoto A; Yoshikawa M; Andoh H; Yano H; Matsumoto H; Kawaguchi M; Oka T; Kobayashi H
Eur J Pharmacol; 2007 Jan; 555(1):17-22. PubMed ID: 17109841
[TBL] [Abstract][Full Text] [Related]
8. Serine racemase protein expression in cortex and hippocampus in schizophrenia.
Steffek AE; Haroutunian V; Meador-Woodruff JH
Neuroreport; 2006 Jul; 17(11):1181-5. PubMed ID: 16837850
[TBL] [Abstract][Full Text] [Related]
9. Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls.
Pålsson E; Jakobsson J; Södersten K; Fujita Y; Sellgren C; Ekman CJ; Ågren H; Hashimoto K; Landén M
Eur Neuropsychopharmacol; 2015 Jan; 25(1):133-40. PubMed ID: 25482684
[TBL] [Abstract][Full Text] [Related]
10. Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients.
Hashimoto K; Engberg G; Shimizu E; Nordin C; Lindström LH; Iyo M
BMC Psychiatry; 2005 Jan; 5():6. PubMed ID: 15683541
[TBL] [Abstract][Full Text] [Related]
11. Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients.
Hashimoto K; Engberg G; Shimizu E; Nordin C; Lindström LH; Iyo M
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):767-9. PubMed ID: 15939521
[TBL] [Abstract][Full Text] [Related]
12. Changes in plasma D-serine, L-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment.
Yamamori H; Hashimoto R; Fujita Y; Numata S; Yasuda Y; Fujimoto M; Ohi K; Umeda-Yano S; Ito A; Ohmori T; Hashimoto K; Takeda M
Neurosci Lett; 2014 Oct; 582():93-8. PubMed ID: 25218715
[TBL] [Abstract][Full Text] [Related]
13. Reduced serine racemase expression contributes to age-related deficits in hippocampal cognitive function.
Turpin FR; Potier B; Dulong JR; Sinet PM; Alliot J; Oliet SH; Dutar P; Epelbaum J; Mothet JP; Billard JM
Neurobiol Aging; 2011 Aug; 32(8):1495-504. PubMed ID: 19800712
[TBL] [Abstract][Full Text] [Related]
14. Structure-function relationships in human D-amino acid oxidase.
Sacchi S; Caldinelli L; Cappelletti P; Pollegioni L; Molla G
Amino Acids; 2012 Nov; 43(5):1833-50. PubMed ID: 22865246
[TBL] [Abstract][Full Text] [Related]
15. The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine.
Smith SM; Uslaner JM; Yao L; Mullins CM; Surles NO; Huszar SL; McNaughton CH; Pascarella DM; Kandebo M; Hinchliffe RM; Sparey T; Brandon NJ; Jones B; Venkatraman S; Young MB; Sachs N; Jacobson MA; Hutson PH
J Pharmacol Exp Ther; 2009 Mar; 328(3):921-30. PubMed ID: 19088300
[TBL] [Abstract][Full Text] [Related]
16. Decreased levels of D-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia.
Errico F; Napolitano F; Squillace M; Vitucci D; Blasi G; de Bartolomeis A; Bertolino A; D'Aniello A; Usiello A
J Psychiatr Res; 2013 Oct; 47(10):1432-7. PubMed ID: 23835041
[TBL] [Abstract][Full Text] [Related]
17. Cellular distribution of D-serine, serine racemase and D-amino acid oxidase in the rat vestibular sensory epithelia.
Dememes D; Mothet JP; Nicolas MT
Neuroscience; 2006 Feb; 137(3):991-7. PubMed ID: 16289842
[TBL] [Abstract][Full Text] [Related]
18. Ketamine enhances the expression of serine racemase and D-amino acid oxidase mRNAs in rat brain.
Takeyama K; Yoshikawa M; Oka T; Kawaguchi M; Suzuki T; Hashimoto A
Eur J Pharmacol; 2006 Jul; 540(1-3):82-6. PubMed ID: 16716293
[TBL] [Abstract][Full Text] [Related]
19. Association between a longer duration of illness, age and lower frontal lobe grey matter volume in schizophrenia.
Premkumar P; Fannon D; Kuipers E; Cooke MA; Simmons A; Kumari V
Behav Brain Res; 2008 Nov; 193(1):132-9. PubMed ID: 18586335
[TBL] [Abstract][Full Text] [Related]
20. Decreased levels of free D-aspartic acid in the forebrain of serine racemase (Srr) knock-out mice.
Horio M; Ishima T; Fujita Y; Inoue R; Mori H; Hashimoto K
Neurochem Int; 2013 May; 62(6):843-7. PubMed ID: 23439386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
